Tedizolid Uses, Dosage, Side Effects and Interactions
Sivextro
Sivextro was the first tedizolid product the FDA approved, in June 2014. No generic is listed as injections and tablets.
Tedizolid is an oxazolidinone antibacterial (antibiotic) used to treat acute bacterial skin and skin structure infections (ABSSSI) caused by certain susceptible bacteria in adults and children.
Quick links
Ask Anything About TedizolidType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Tedizolid in Short
- Drug class Oxazolidinone Antibacterial How the FDA classifies it
What it treatsTedizolid treats acute bacterial skin and skin structure infections (ABSSSI). These are serious skin infections caused by certain gram-positive bacteria. Sivextro is used for adults and for children at least 26 weeks gestational age and weighing at least 1 kg.
- How you get it Prescription only
- Comes asInjection and tabletAvailable strengths
Injection (into a vein)
- 200 mg/4 mL
Tablet (by mouth)
- 200 mg
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- What pharmacies pay
- Sivextro (brand)$475.79 a tablet
- Generic launchDecember 2030 Our estimate for the first generic of Sivextro
The Pharmacist’s Take
Tedizolid (Sivextro), on the market since about 2014, is a newer cousin of the antibiotic linezolid that stops bacteria from making the proteins they need. It is usually a specialist choice for serious skin infections, including MRSA (staph that resists many common antibiotics). It is generally well tolerated, and nausea, headache and diarrhea are what people notice most. Watch for serotonin syndrome (fever, heavy sweating, agitation, twitching or stiff muscles), a real risk alongside antidepressants, migraine triptans or opioids. Diarrhea during the course or even months after it needs a call, since it can signal C. difficile, a serious gut infection.
Key Takeaways From the HelloPharmacist Team
- Expect a short course, once a day for 6 days, as a tablet taken with or without food or as a one-hour IV infusion.
- Report unusual bruising or bleeding, since low platelets have been reported, mostly when treatment ran past the approved 6 days.
- If you take rosuvastatin or methotrexate, ask your prescriber whether to pause it, since tedizolid tablets can raise their levels.
Patient Information Guide for Tedizolid
What It’s Used For
Tedizolid is an antibiotic used for one main type of infection.
- Acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria, including MRSA and MSSA strains of Staphylococcus aureus, certain Streptococcus species, and Enterococcus faecalis.
- Sivextro (IV and tablet) is for adults and for children at least 26 weeks gestational age and weighing at least 1 kg. Tablets are only for children weighing at least 35 kg.
How It Works
Tedizolid is an antibacterial drug in the oxazolidinone class. Sivextro contains tedizolid phosphate, a prodrug (an inactive form) that the body converts into the active drug, tedizolid, after it is taken by mouth or by IV.
Drug Class
Drug Class
- Oxazolidinone Antibacterial
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Oxazolidinone Antibacterial
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Breast Cancer Resistance Protein Inhibitors
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Tedizolid in the FDA’s index.
From our Patient Information GuideTedizolid is an antibacterial drug in the oxazolidinone class. Sivextro contains tedizolid phosphate, a prodrug (an inactive form) that the body converts into the active drug, tedizolid, after it is taken by mouth or by IV. Read How Tedizolid Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Oxazolidinones
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Other antibacterials
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Sivextro comes as a once-daily tablet or an IV infusion given over 1 hour. For adults, the course is 6 days.
The tablet can be taken with or without food.
- Switching from IV to oral does not require a dose change.
- Missed tablet: take it as soon as possible, up to 8 hours before the next dose. If less than 8 hours remain, wait for the next dose.
- Children's doses depend on weight, and the IV schedule varies by weight.
Follow your prescriber's directions and the label.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Tedizolid Injection
Serious skin infections
Adults Usual dose 200 mg once daily
- 200 mg once daily as an IV infusion over 1 hour for 6 days
Good to know
No dose adjustment when changing from intravenous to oral
IV means given into a vein (intravenous).
Children weighing 1 kg to less than 2 kg Usual dose 3 mg/kg twice a day
- 3 mg/kg twice daily, 1 hour infusion, for 6 days
Good to know
Based on actual body weight
Children weighing 2 kg to less than 3 kg Usual dose 6 mg twice a day
- 6 mg twice daily, 1 hour infusion, for 6 days
Children weighing 3 kg to less than 6 kg Usual dose 12 mg twice a day
- 12 mg twice daily, 1 hour infusion, for 6 days
Children weighing 6 kg to less than 10 kg Usual dose 20 mg twice a day
- 20 mg twice daily, 1 hour infusion, for 6 days
Children weighing 10 kg to less than 14 kg Usual dose 30 mg twice a day
- 30 mg twice daily, 1 hour infusion, for 6 days
Children weighing 14 kg to less than 20 kg Usual dose 40 mg twice a day
- 40 mg twice daily, 1 hour infusion, for 6 days
Children weighing 20 kg to less than 35 kg Usual dose 60 mg twice a day
- 60 mg twice daily, 1 hour infusion, for 6 days
Children weighing 35 kg or more Usual dose 200 mg once daily
- 200 mg once daily, 1 hour infusion, for 6 days
Tedizolid Taken by Mouth
Serious skin infections
Adults Usual dose 200 mg once a day
- 200 mg once daily for 6 days
Good to know
With or without food; no dose adjustment when changing from intravenous to oral
Children weighing 35 kg or more Usual dose 200 mg once a day
- 200 mg once daily for 6 days
Good to know
Not for children weighing less than 35 kg; with or without food
Side Effects
Most side effects are mild and stomach-related.
Common side effects
- Nausea
- Headache
- Diarrhea
- Vomiting
- Dizziness
- Infusion- or injection-site reactions (such as phlebitis, vein irritation)
- Increased liver enzymes on blood tests (more often noted in teens)
- In children and teens: vein irritation (phlebitis) and increased liver enzymes
When to get medical help
- Get help right away if you develop fever, heavy sweating, agitation, muscle stiffness or twitching, tremor, or very strong reflexes. These can be signs of serotonin syndrome, especially if you take other serotonin-affecting medicines.
- Call your doctor if you get diarrhea during or after treatment. It can be a sign of C. difficile infection, which can happen even more than two months after an antibiotic.
- Tell your doctor about unusual bruising or bleeding. Low platelets (thrombocytopenia) have been reported, mostly with use longer than the approved 6 days.
- Report any severe or worsening symptoms to your care team promptly.
Warnings and Precautions
- Serotonin syndrome: can occur with other serotonin-affecting medicines. Symptoms include fever, sweating, agitation, tremor and muscle stiffness.
- C. difficile diarrhea: can range from mild to fatal colitis and may appear weeks after treatment.
- Neutropenia: safety and effectiveness have not been adequately evaluated, so other therapies may be considered.
- Low platelets: reported mostly with use longer than 6 days, which is not approved.
- Drug resistance: use only for proven or strongly suspected bacterial infections.
Interactions
A few medicine types need extra care with tedizolid.
- Serotonergic medicines (SSRIs, SNRIs, tricyclic antidepressants, buspirone, triptans, opioids including meperidine): raise the risk of serotonin syndrome.
- BCRP substrates (such as methotrexate, topotecan, rosuvastatin): oral Sivextro can raise their blood levels, so your prescriber may pause them or monitor you.
Interactions Listed in the FDA-Approved Label
From the Tedizolid prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Breast Cancer Resistance Protein (BCRP) substrates (e.g., methotrexate, topotecan, rosuvastatin)What happensOrally administered SIVEXTRO inhibits BCRP in the intestine, which can increase plasma concentrations of orally administered BCRP substrates and the potential for adverse reactions.What to doIf possible consider interrupting the BCRP substrate during treatment, especially those with a narrow therapeutic index; if coadministration cannot be avoided, monitor for adverse reactions.
-
Serotonergic agentsWhat happensSerotonin syndrome has been reported in postmarketing experience in patients taking SIVEXTRO with serotonergic agents.
Read the label’s full interactions text
7 DRUG INTERACTIONS SIVEXTRO (when administered orally) can increase the plasma concentrations of orally administered Breast Cancer Resistance Protein (BCRP) substrates. Monitor for adverse reactions related to the concomitant BCRP substrates if coadministration cannot be avoided. SIVEXTRO has the potential for interaction with serotonergic agents. 7.1 Membrane Transporters Orally administered SIVEXTRO inhibits Breast Cancer Resistance Protein (BCRP) in the intestine, which can increase the plasma concentrations of orally administered BCRP substrates, and the potential for adverse reactions. If possible, an interruption in the treatment of the co-administered BCRP substrate medicinal product should be considered during treatment with SIVEXTRO, especially for BCRP substrates with a narrow therapeutic index (e.g., methotrexate or topotecan). If coadministration cannot be avoided, monitor for adverse reactions related to the concomitantly administered BCRP substrates, including rosuvastatin. 7.2 Serotonergic Agents In postmarketing experience, there have been reports of serotonin syndrome in patients taking SIVEXTRO with serotonergic agents.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- No contraindications are listed for Sivextro.
- Tell your doctor if you have neutropenia.
- Pregnancy: animal studies show possible fetal harm, and human data are insufficient.
- Breastfeeding: it is unknown whether tedizolid is in breast milk, so discuss the risks and benefits with your doctor.
- Children: tablets are not for children weighing less than 35 kg.
- Older adults: no overall differences in how the body handles the drug were seen.
- Kidney or liver problems: no dose adjustment is needed, and hemodialysis does not meaningfully remove the drug.
Overdose
If an overdose happens, Sivextro should be stopped and general supportive care given. Hemodialysis does not meaningfully remove tedizolid from the blood.
Half-Life and How Your Body Processes It
The tablet is well absorbed (about 91% bioavailable), with peak levels in roughly 3 hours by mouth, or at the end of a 1-hour IV infusion. Food does not change overall exposure. Steady levels are reached in about 3 days, and the half-life is about 12 hours.
Tedizolid is not broken down by liver CYP450 enzymes. It is cleared mostly through the liver into feces, and most is eliminated within 96 hours. Age, weight, and kidney or liver function did not meaningfully change levels.
Storage
SIVEXTRO Tablets and SIVEXTRO for Injection should be stored at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Tedizolid: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Tedizolid — the kind of thing our pharmacy team would talk through with you at the counter.
What is tedizolid used for?
What happens if I miss a dose of tedizolid?
Can I take tedizolid with food?
What side effects should I expect, and when should I call?
Can I take tedizolid with my antidepressant?
Is tedizolid safe in pregnancy?
Is tedizolid available over the counter?
When was tedizolid first available?
What is the brand name of tedizolid?
What is the generic name of Sivextro?
What drug class is tedizolid?
What strengths does tedizolid come in?
How much does tedizolid cost?
Is there a tedizolid shortage?
Where can I read the tedizolid prescribing information (package insert)?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Tedizolid
Skip the scrolling. Ask in your own words and get an answer from Tedizolid’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Tedizolid’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Tedizolid on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, usually within a day.Tedizolid Forms and Strengths (How It Comes)
Tedizolid comes in 2 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Tedizolid inactive ingredients by manufacturer.
Injection
How this form is used
- Sivextro treats acute bacterial skin and skin structure infections (ABSSSI) in adults and in children at least 26 weeks gestational age and weighing at least 1 kg.
- Sivextro for injection is given as an IV infusion over 1 hour.
- Sivextro IV dosing in children is weight-based, and the schedule depends on weight.
- Sivextro vials are single-dose and are prepared by a healthcare professional.
Tablet
How this form is used
- Sivextro tablets treat ABSSSI in adults and in children weighing at least 35 kg.
- Sivextro tablets can be taken with or without food.
- Sivextro tablets are taken once daily for 6 days in adults.
- Sivextro tablets must not be given to children weighing less than 35 kg.
- If you miss a Sivextro tablet, take it as soon as possible, up to 8 hours before your next scheduled dose. If less than 8 hours remain, wait for the next dose.
Tedizolid on the U.S. Market: Products, Makers and Brands
How Tedizolid appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
1 company lists 2 Tedizolid product records with the FDA, mostly as injection, tablet; the earliest marketing or approval year on record is 2014. The one brand name in the directory today is Sivextro; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (3) · Unfinished injection, powder, lyophilized, for solution (1) · Unfinished tablet, coated (1) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
How Widely Tedizolid Is Used (Medicaid Data)
How many Tedizolid prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Tedizolid prescribed? Of the 1,682 medications we measure, Tedizolid ranks #1,581 by Medicaid prescriptions — more than 6% of them.
Utilization by Tedizolid product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
tedizolid phosphate 200 MG Oral Tablet
2 of 7 listed NDCs had Medicaid claims. RxNorm 1540862
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 2 of the 7 listed Tedizolid NDCs had Medicaid claims.
Compare Tedizolid Products
A representative set of FDA-listed product records for Tedizolid — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 200 mg/4 mL | Intravenous | Merck Sharp & Dohme LLC | NDA | View NDC → |
| 💊Tablet | ||||
| 200 mg | Oral | Merck Sharp & Dohme LLC | NDA | View NDC → |
Showing 2 of 2 products — FDA National Drug Code Directory. See every product, package size and price: browse all 2 Tedizolid NDCs →
Tedizolid Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Tedizolid — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Tedizolid in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Tedizolid FDA Approval History
How Tedizolid went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Tedizolid Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Tedizolid recalls since July 2021.
✅No Tedizolid recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Tedizolid in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 2
- Strengths
- 2
- Forms in current FDA listings
- 2 of 2
RxCUI 1540825 RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Tedizolid Supply and Shortage Status
Whether Tedizolid is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Tedizolid Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Tedizolid: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a strength to see how its price has changed since Jan 2025.
For brand-name Sivextro, the 200 mg tablet, pharmacies paid an average of $475.79 per tablet as of Nov 18, 2026, up 6.8% from $445.50 a year earlier.
- What pharmacies pay now
- $475.79
- per tablet, as of Nov 18, 2026
- Last 4 weeks
- No change
- from $475.79 on Oct 21, 2026
- Last 12 months
- Up 6.8%
- from $445.50 on Nov 19, 2025
- Lowest and highest since Jan 2025
- $445.50 to $475.79
- per tablet
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $475.79 |
| Oct 2026 | $475.79 |
| Sep 2026 | $475.79 |
| Aug 2026 | $472.95 |
| Mar 2026 | $472.23 |
| Feb 2026 | $472.23 |
| Jan 2026 | $472.23 |
| Dec 2025 | $445.50 |
| Nov 2025 | $445.50 |
| Oct 2025 | $445.50 |
| Sep 2025 | $445.50 |
| Aug 2025 | $445.50 |
| Jul 2025 | $445.50 |
| Jun 2025 | $445.50 |
| May 2025 | $445.50 |
| Apr 2025 | $445.50 |
| Mar 2025 | $445.50 |
| Feb 2025 | $445.50 |
| Jan 2025 | $445.50 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Tablet · Oral | 200 mg | Sivextro (brand) | $475.79 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Tedizolid Brand Names
Tedizolid has one brand name on record: Sivextro. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Tedizolid: Manufacturers and Labelers
One company lists Tedizolid products with the FDA. By number of product records, the largest are Merck Sharp & Dohme LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Tedizolid Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Merck Sharp & Dohme LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →